the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
June 09, 2017 – It’s only a couple of days that the American Food & Drug Administration (FDA) approved for the first time a cancer treatment for any solid tumor, irrespective of the tumor’s original location, as long as the targeted tumor is …
Biomarker-guided Larotrectinib for all cancer types? Read more »
May 24, 2917 – The American Food & Drug Administration (FDA) just approved a major extension of the clinical indications for Pembrolizumab (Keytruda). For the first time, a cancer treatment has been approved for any solid tumor, irrespective of the tumor’s …
First cancer treatment for any solid tumor with MSI-H or dMMR approved Read more »